The Chinese government has formulated an ambitious healthcare reform plan which will engage a large amount of resources to improve the healthcare infrastructures in China. Within the next 10 years, this infrastructure will work to raise healthcare insurance coverage, as well as reallocate interests among hospitals, drug manufacturers, drug distributors and patients. While this remarkable reform will provide tremendous opportunities for various players in the value chain, it will at the same time pose significant challenges.
Kamex keeps up with the development of the Chinese healthcare system and be sure that the best people are in out network. We provide services to various types of clients, including pharmaceutical companies, medical device manufacturers and hospital management organizations.

Sectors We Served:
 - Medical Devices & Diagnostics
 - Biotechnology
 - Pharmaceuticals
 - Hospitals
 - Healthcare Service